Finzati - Logo
LIN logo

Linde plc

LINChemicals - Specialty
$477.57
-4.62 (-0.96%)
Current price
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$221.84B
Growth
6.1%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 20.3%Positive revenue growth · 5.2%Positive free cash flow · 10.91Consistent free cash flow · 5/5Manageable debt level · 0.71
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$477.57
Change-0.96%
Shares Out464.52M
Market Cap$221.84B
Enterprise Value$242.48B
52W Range387.78 - 548.20
Beta0.72
P/E30.44
P/S6.26
P/B5.68
P/FCF44.59
EV/Sales6.84

Investment DNA

How strong this company looks for long-term investors

70
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
59/100
Growth Potential
Revenue and expansion
45/100
Price Attractiveness
Cheap or expensive today
49/100
Why this score
Stable or improving margins · 20.3%Positive revenue growth · 5.2%Positive free cash flow · 10.91Consistent free cash flow · 5/5Manageable debt level · 0.71Weak liquidity · 0.88

Analyst view

Analyst sentiment and price target

LIN
Analyst sentiment
Based on 28 analyst votes · 2026-09-05
95/100
Bullish
Bullish
25
Hold
3
Bearish
0
Price Target
2026-08-02
Low
$525.00
Mean
$557.67
Median
$560.00
High
$600.00

Company Overview

IPO: 6/17/1992
Industry: Chemicals - Specialty
P/B i: 5.68
Debt / Equity i: 0.71
Operating Margin: 26.29%
Net Margin: 20.30%
ROE i: -
ROIC: -

Financial Health

Score12 / 20
Debt / Equity: 0.71
Current Ratio: 0.88
Quick Ratio: 0.74
Status: Good

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

Reynolds Paula Rosput
Transaction: 07/01/2026
BUY
Change
Price
Not reported
Filing
07/02/2026
Type
BUY
GRANT HUGH
Transaction: 07/01/2026
BUY
Change
Price
Not reported
Filing
07/02/2026
Type
BUY
Innocenzi Stefanos
Transaction: 06/08/2026
SELL
Change
-4,035
Price
Not reported
Filing
06/10/2026
Type
SELL